Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Mary Fletcher-Louis"'
Autor:
Mary Fletcher-Louis, Abby Paine, Tam Dang-Tan, Jatin Gupta, Brian Bekker Hansen, Solomon Nuhoho
Publikováno v:
Diabetes Therapy
Introduction Orally administered semaglutide is the first glucagon-like peptide 1 receptor agonist (GLP-1 RA) for oral administration. As head-to-head trials assessing orally administered semaglutide as an add-on to 1–2 oral antidiabetic drugs (OAD
Autor:
Mary Fletcher-Louis, François Pattou, Fiachra Bolger, Ulrik Haagen Panton, Javier Salvador, Katrin Nather, Ana-Paula Cancino, Laurie DiModica
Publikováno v:
Clinical Obesity
Summary Obesity is a risk factor for severe complications from coronavirus disease 2019 (COVID‐19). During the COVID‐19 pandemic in Spring 2020, many clinics and obesity centers across Europe were required to close. This study aimed to determine